Tower Cancer Research Foundation Integrates Work and Assets of the Dr. Susan Love Foundation for Breast Cancer Research and Announces Visionary New CEO Christopher Clinton Conway
Conway brings a wealth of philanthropic and executive leadership experience and counsel, and a passion for changing the course of cancer.
- Conway brings a wealth of philanthropic and executive leadership experience and counsel, and a passion for changing the course of cancer.
- TCRF's Board of Directors voted in early January 2024 to integrate the work and assets of Dr. Susan Love (1948-2023), founder and Chief Visionary Officer of the Dr. Susan Love Foundation for Breast Cancer Research, into TCRF.
- Dr. Love was an internationally renowned and compassionate trailblazer in the work to end breast cancer.
- TCRF is now at the forefront of this work, extending its reach by establishing the Dr. Susan Love Fund for Breast Cancer Research .